Logo-bma
biomedad.ae. 2024;1(1): 2-11. doi: 10.34172/bma.02

Review Article

Regenerative medicine and congenital heart diseases: Current approaches and future directions

Buse Sanli ORCID, Mohammadreza Dastouri * ORCID

Cited by CrossRef: 0

1- Loomba R, Thrush P, Gambetta K, Madden B, Magnetta D, Mejia E, Morrison A, Ashrafi A, Levy V, Flores S. Novel and Precision Therapies in Neonatal Heart Failure. Curr Treat Options Peds. 2026;12(1) [Crossref]

Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.

Scientific Support by